|
|
Christophe Foucher
Chief Operating Officer
Mr Foucher was appointed Chief Operating Officer in May 2009 and is responsible for all commercial supply chain and manufacturing activities in the Group. Prior to this he held the positions of General Manager for Sinclair Pharma France and Southern Europe Director, in charge of operations in Italy and Spain.Mr Foucher has 14 years experience in the pharmaceutical industry at senior level in Europe, Africa and Asia. Mr Foucher has a doctorate degree in Pharmacy, an INSEAD diploma in Finance and an MBA from IAE. He is fluent in English, French and Italian. |
|
Paul Phull
Executive Vice-President – International Operations
Mr Phull has overall responsibility for Sinclair’s International operations, working to develop sales of Sinclair’s brands globally via existing partners and identifying opportunities for collaboration with new partners. Mr Phull is an experienced executive in international pharmaceutical commercialisation, having worked in sales, marketing and business development in the healthcare industry for over 20 years.
|
|
Alan Olby
Finance Director and Company Secretary
Mr Olby has responsibility for the finance operations across the Group, including financial reporting, financing and tax planning.Mr Olby joined Sinclair in September 2005 having gained experience in the biotech sector working at Xenova Group plc and KS Biomedix plc. He qualified as a chartered accountant in 1996 and subsequently worked in corporate finance at Deloitte, supporting public and private companies with due diligence, working capital reviews and stock exchange transactions.
|
|
Marco Mastrodonato
Executive Vice-President
Mr Mastrodonato has headed up the Business Development, Licensing and Products Development Division of Sinclair Pharma since the acquisition of Propharma Srl by the Company in May 2001. In 2004 with the acquisition of Euroderm Spa, the operating company in Italy (now Sinclair Srl), Mr Mastrodonato was nominated Chairman of the Board for the local Italian subsidiary which is responsible for detailing the Sinclair Dermatology products in the Italian Market. Mr Mastrodonato founded Propharma Srl in 1999 and invented Gelclair®, Aloclair®, Xclair®, Atopiclair®, Sebclair®, Dermachronic®, Sinlice, Decapinol® Perioapplicator, Decapinol® Gel and Decapinol® Toothpaste. Between 1996 and 1998 Mr Mastrodonato worked as a consultant for Carrington Laboratories Inc, a US research-based bio-pharmaceutical company, licensing and exporting products from the US to Europe. Prior to 1998, Mr Mastrodonato founded Protema Spa, an Italian agro-chemical company. Between 1989 and 1996 he founded the European Operation of an international clinical research organisation, AAI Pharma Inc. and between 1987 and 1989 he worked for the independent company OEMF Spa, publishers of the pharmaceutical directory, Informatore Farmaceutico.
|
|
Mike Killeen
Executive Vice President, North America
Mr Killeen joined following the acquisition of Propharma Srl in May 2001. At Propharma Srl, Mr Killeen held the position of Vice President of Sales and Marketing for the US and Pacific Rim. Prior to joining Propharma Srl, Mr Killeen was Director of Sales and Marketing at Carrington Laboratories Inc., prior to which he was Director of Business Development at Horizon Medical Inc.
|
 |
Steve Redman
Legal Director
Steve Redman joined Sinclair as its first in-house Legal Director in July 2007, from his previous role at Schering Health Care. He is a barrister and brings to the Sinclair Group more than 20 years experience as senior legal counsel in the financial services, insurance and pharmaceutical sectors. During this time he has supported the business growth of these employers by providing authoritative and practical advice in a wide variety of legal areas that includes multi-national transactions, commercial contracts, licencing, intellectual property, completion, corporate, EU law as well as regulatory compliance.
|
| To the top↑ |
|
